A detailed history of Coldstream Capital Management Inc transactions in Viatris Inc stock. As of the latest transaction made, Coldstream Capital Management Inc holds 23,101 shares of VTRS stock, worth $288,300. This represents 0.01% of its overall portfolio holdings.

Number of Shares
23,101
Previous 23,065 0.16%
Holding current value
$288,300
Previous $245,000 9.39%
% of portfolio
0.01%
Previous 0.01%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

BUY
$10.32 - $12.13 $371 - $436
36 Added 0.16%
23,101 $268,000
Q2 2024

Aug 07, 2024

SELL
$10.05 - $12.02 $50 - $60
-5 Reduced 0.02%
23,065 $245,000
Q1 2024

May 13, 2024

SELL
$11.27 - $13.53 $4,406 - $5,290
-391 Reduced 1.67%
23,070 $275,000
Q4 2023

Feb 09, 2024

BUY
$8.77 - $10.85 $59,329 - $73,400
6,765 Added 40.52%
23,461 $254,000
Q3 2023

Nov 02, 2023

BUY
$9.59 - $11.35 $18,374 - $21,746
1,916 Added 12.96%
16,696 $164,000
Q2 2023

Aug 03, 2023

SELL
$9.02 - $10.29 $13,097 - $14,941
-1,452 Reduced 8.95%
14,780 $147,000
Q1 2023

May 15, 2023

SELL
$9.2 - $12.26 $13,919 - $18,549
-1,513 Reduced 8.53%
16,232 $156,000
Q4 2022

Jan 10, 2023

BUY
$8.72 - $11.56 $26,944 - $35,720
3,090 Added 21.08%
17,745 $0
Q2 2022

Aug 08, 2022

BUY
$9.95 - $12.27 $45,381 - $55,963
4,561 Added 45.19%
14,655 $154,000
Q2 2022

Aug 08, 2022

BUY
$9.95 - $12.27 $100,435 - $123,853
10,094 New
10,094 $106,000
Q1 2022

May 11, 2022

SELL
$9.81 - $15.4 $119,191 - $187,110
-12,150 Closed
0 $0
Q4 2021

Feb 11, 2022

BUY
$12.09 - $14.68 $146,893 - $178,362
12,150 New
12,150 $164,000
Q1 2021

Jun 16, 2021

SELL
$13.59 - $18.54 $224,751 - $306,614
-16,538 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$14.3 - $18.74 $236,493 - $309,922
16,538 New
16,538 $310,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $15.1B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Coldstream Capital Management Inc Portfolio

Follow Coldstream Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Coldstream Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Coldstream Capital Management Inc with notifications on news.